Reardon Wilson Cavanagh syndrome
Other Names: Familial ataxia, deafness, and developmental delay; Ataxia, hearing loss, and mental retardation; Ataxia-deafness-retardation syndrome; ADR syndrome
This syndrome is characterised by progressive ataxia beginning during childhood, deafness and intellectual deficit.
Epidemiology[edit]
It has been described in two families.
Inheritance[edit]

Transmission may be X-linked recessive.
Signs and symptoms[edit]
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.
80%-99% of people have these symptoms
- Ataxia
- Intellectual disability(Mental deficiency)
- Nystagmus(Involuntary, rapid, rhythmic eye movements)
- Sensorineural hearing impairment
- Strabismus(Cross-eyed)
30%-79% of people have these symptoms
- Abnormal palate morphology(Abnormality of the palate)
- Aplasia/Hypoplasia of the cerebellum(Absent/small cerebellum)
- Cerebral cortical atrophy(Decrease in size of the outer layer of the brain due to loss of brain cells)
- Decreased nerve conduction velocity
- EMG abnormality
- Muscular hypotonia(Low or weak muscle tone)
- Neurological speech impairment(Speech disorder)
- Reduced tendon reflexes
- Scoliosis
- Skeletal muscle atrophy(Muscle degeneration)
- Ventriculomegaly
5%-29% of people have these symptoms
- Joint hyperflexibility(Joints move beyond expected range of motion)
Differential diagnosis[edit]
The clinical picture is similar to that seen in Richards-Rundle syndrome.
NIH genetic and rare disease info[edit]
Reardon Wilson Cavanagh syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Reardon Wilson Cavanagh syndrome
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
